Get the Stockscreener App
4.88
2.95%
0.14
After Hours:
4.87
-0.010
-0.20%
Cvrx Inc stock is traded at $4.88, with a volume of 248.25K.
It is up +2.95% in the last 24 hours and down -16.72% over the past month.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
See More
Previous Close:
$4.74
Open:
$4.81
24h Volume:
248.25K
Relative Volume:
0.81
Market Cap:
$129.50M
Revenue:
$59.07M
Net Income/Loss:
$-52.66M
P/E Ratio:
-2.4279
EPS:
-2.01
Net Cash Flow:
$-40.16M
1W Performance:
+2.31%
1M Performance:
-16.72%
6M Performance:
-35.28%
1Y Performance:
-41.49%
1-Day Range:
$4.75
$5.00
1-Week Range:
$4.68
$5.10
52-Week Range:
$4.3701
$11.30
Cvrx Inc Stock (CVRX) Company Profile
Name
Cvrx Inc
Sector
Industry
Phone
(763) 416-2850
Address
9201 WEST BROADWAY AVENUE, MINNEAPOLIS
Compare CVRX vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CVRX
Cvrx Inc
|
4.88 | 125.78M | 59.07M | -52.66M | -40.16M | -2.01 |
ABT
Abbott Laboratories
|
104.49 | 179.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
336.74 | 126.60B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
84.22 | 106.51B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
45.51 | 65.77B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
83.04 | 47.58B | 6.30B | 1.07B | 1.09B | 1.8406 |
Cvrx Inc Stock (CVRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-09-25 | Downgrade | JP Morgan | Neutral → Underweight |
| Jan-14-25 | Upgrade | William Blair | Mkt Perform → Outperform |
| Sep-10-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-11-24 | Reiterated | Lake Street | Buy |
| May-01-24 | Resumed | Craig Hallum | Buy |
| May-01-24 | Downgrade | JP Morgan | Overweight → Neutral |
| May-01-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jan-31-23 | Initiated | Lake Street | Buy |
| Jul-18-22 | Initiated | Craig Hallum | Buy |
| Jul-26-21 | Initiated | Canaccord Genuity | Buy |
| Jul-26-21 | Initiated | Piper Sandler | Overweight |
| Jul-26-21 | Initiated | William Blair | Outperform |
View All
Cvrx Inc Stock (CVRX) Latest News
CVRx Inc (CVRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CVRx Inc (CVRX) Balance Sheet - TradingKey
CVRx Inc (CVRX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
CVRX|CVRx Inc|Price:4.740|Chg%:-0.150 - TradingKey
CVRx Inc (CVRX) Cash Flow - TradingKey
CVRX|CVRx Inc|Price:4.815|Chg%:+0.075 - TradingKey
CVRx Inc (CVRX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CVRx (CVRX) Q4 2025 earnings summary - Quartr
CVRx to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call on August 6, 2026 - The Manila Times
CVRx Plans Aug. 6 Webcast on Second-Quarter Results - Stock Titan
CVRx (CVRX) Proxy filing Summary - Quartr
CVRx partners with Piedmont Columbus Regional Medical Center for first Barostim implant - Traders Union
CVRx (CVRX) The 44th Annual William Blair Growth Stock Conference Summary - Quartr
CVRx (CVRX) Goldman Sachs 47th Annual Global Healthcare Conference 2026 Summary - Quartr
Craig-Hallum Maintains CVRx Inc(CVRX.US) With Buy Rating - 富途牛牛
CVRx Inc (CVRX) Stock Forum and Discussion - Moomoo
(CVRX) Risk Channels and Responsive Allocation - Stock Traders Daily
CVRx Inc(CVRX) Stock Options Chain | Quotes & News - Moomoo
CVRX Technical Analysis | Trend, Signals & Chart Patterns - ChartMill
Cleveland Clinic Florida adopts Barostim implant in collaboration with CVRx - Traders Union
CVRx Inc focuses on heart failure devices as investors watch Nasdaq listing - Ad-hoc-news.de
CVRx (CVRX) Piper Sandler 36th Annual Healthcare Conference Summary - Quartr
CVRx enables first commercial Barostim implant in Washington state for heart failure treatment - Traders Union
CVRx Inc focuses on cardiovascular innovation amid thin market signals - Ad Hoc News
CVRX Q1 2026 Earnings: EPS Beats Estimates as Loss NarrowsRevenue Breakdown Analysis - dars.gov.et
Lake Street Maintains CVRx Inc(CVRX.US) With Buy Rating, Maintains Target Price $14 - Moomoo
Enterprise value to EBIT forward of CVRx, Inc. – NASDAQ:CVRX - TradingView
CVRX,INVA Volatility & Greeks - Finviz
CVRx shares rise on CMS inclusion for Barostim implant procedure - MSN
CVRx (CVRX) moves 11.6% higher: Will this strength last? - MSN
CVRX Q1 2026 Earnings: EPS Exceeds Estimates as Company Navigates Market ChallengesMid-Term Outlook - dars.gov.et
CVRx Inc. (CVRX) Sinks 13.5% as Selling Pressure Intensifies Near Key SupportKeltner Channel - dars.gov.et
CVRX Q1 2026 Earnings: EPS Beats Estimates Amid Operational ProgressEarnings Manipulation Risk - dars.gov.et
CVRx Inc (CVRX) Analyst Ratings, Stock Forecast and Price Target - Moomoo
CVRx (CVRX) Moves 11.6% Higher: Will This Strength Last? - Yahoo Finance
CVRx Inc. Surges on Strong Trading Activity; Key Resistance Levels AheadTriple Bottom - dars.gov.et
Price to earnings forward of CVRx, Inc. – NASDAQ:CVRX - TradingView
Enterprise value to revenue forward of CVRx, Inc. – NASDAQ:CVRX - TradingView
Price to book forward of CVRx, Inc. – NASDAQ:CVRX - TradingView
CVRx, Inc. Actuals & Estimates (NASDAQ:CVRX) - TradingView
CVRX Forecast — Price Target — Prediction for 2027 - TradingView
(CVRX) Movement as an Input in Quant Signal Sets - Stock Traders Daily
CVRx Inc (CVRX) Institutional Confidence - TradingKey
CVRx stock up on Humana's Medicare coverage for Barostim therapy - MSN
CVRx Inc (CVRX) Stock Forecast & Analyst Ratings - Moomoo
CVRX Q1 2026 Earnings: EPS Beats Estimates as Pre‑Revenue Progress Drives Stock HigherEarnings Quality Analysis - dars.gov.et
CVRx Inc (CVRX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CVRx to present Barostim integration strategies at AAHFN Annual Meeting - Traders Union
CVRx Inc (CVRX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
CVRx Inc (CVRX) Valuation: PE, PB & Fair Value Analysis - TradingKey
CVRx Inc (CVRX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cvrx Inc Stock (CVRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.79%
4.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):